The real-life experience of vedolizumab efficacy and safety in ulcerative colitis: a prospective observational multicentre cohort study

被引:0
|
作者
Amiot, A. [1 ]
Peyrin-Biroulet, L. [2 ]
Stefanescu, C. [3 ]
Grimaud, J. C. [4 ]
Filippi, J. [5 ]
Pariente, B. [6 ]
Roblin, X. [7 ]
Altwegg, R. [8 ]
Laharie, D. [9 ]
Marteau, P. [10 ]
Buisson, A. [11 ]
Trang-Poisson, C. [12 ]
Nancey, S. [13 ]
Savoye, G. [14 ]
Viennot, S. [15 ]
Brixi-Benmansour, H. [16 ]
Carbonnel, F. [17 ]
Bouhnik, Y. [3 ]
机构
[1] Henri Mondor Hosp, Gastroenterol, Creteil, France
[2] CHU Nancy, Dept Gastroenterol & Hepatol, Vandoeuvre Les Nancy, France
[3] APHP Beaujon, Dept Gastroenterol, Clichy, France
[4] Hosp Nord, Dept Gastroenterol & Hepatol, Marseille, France
[5] Archet 2 Hosp, Dept Gastroenterol, Nice, France
[6] CHRU Lille, Dept Gastroenterol, Lille, France
[7] Univ St Etienne, Dept Gastroenterol, St Etienne, France
[8] CHU Montpellier St Eloi Hosp, Dept Gastroenterol, Montpellier, France
[9] CHU Bordeaux, Dept Gastroenterol, Bordeaux, France
[10] Hosp Lariboisiere, Dept Gastroenterol, Paris, France
[11] CHU Estaing, Dept Gastroenterol, Clermont Ferrand, France
[12] CHU Hotel Dieu, Dept Gastroenterol, Nantes, France
[13] Hosp Edouard Herriot, Dept Gastroenterol & Hepatol, Lyon, France
[14] CHU Rouen, Dept Gastroenterol, Rouen, France
[15] Hosp Cote Nacre, Dept Gastroenterol, Caen Cede, France
[16] Robert Debre Hosp, Dept Gastroenterol, Reims, France
[17] CHU Bicetre, Dept Gastroenterol, Le Kremlin Bicetre, France
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P306
引用
收藏
页码:S247 / S248
页数:2
相关论文
共 50 条
  • [31] Efficacy and safety of retreatment with vedolizumab in patients with ulcerative colitis
    Sands, B. E.
    Shafran, I.
    Farraye, F. A.
    Cheifetz, A. S.
    Abhyankar, B.
    Sankoh, S.
    Smyth, M.
    [J]. JOURNAL OF CROHNS & COLITIS, 2015, 9 : S37 - S37
  • [32] An Observational Study of the Efficacy and Safety of Voriconazole in a Real-Life Clinical Setting
    Blanco-Dorado, Sara
    Cea-Arestin, Cristina
    Gonzalez Carballo, Alba
    Latorre-Pellicer, Ana
    Maronas Amigo, Olalla
    Barbeito Castineiras, Gema
    del Molino Bernal, Maria Luisa Perez
    Campos-Toimil, Manuel
    Fernandez-Ferreiro, Anxo
    Lamas, Maria J.
    [J]. JOURNAL OF CHEMOTHERAPY, 2019, 31 (01) : 49 - 57
  • [33] Compared efficacy and safety of vedolizumab and infliximab in ulcerative colitis after failure of a first subcutaneous anti-TNF agent: a multicentre cohort study
    Hupe, Marianne
    Riviere, Pauline
    Nancey, Stephane
    Roblin, Xavier
    Altwegg, Romain
    Filippi, Jerome
    Fumery, Mathurin
    Bouguen, Guillaume
    Peyrin-Biroulet, Laurent
    Bourreille, Arnaud
    Caillo, Ludovic
    Simon, Mireille
    Goutorbe, Felix
    Laharie, David
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (09) : 852 - 860
  • [34] GOLIMUMAB IN ULCERATIVE COLITIS: A "REAL LIFE" OBSERVATIONAL STUDY
    Capoferro, E.
    [J]. DIGESTIVE AND LIVER DISEASE, 2017, 49 : E207 - E208
  • [35] Efficacy and safety of rituximab in myasthenia gravis: a French multicentre real-life study
    Dos Santos, A.
    Noury, J. -B.
    Genestet, S.
    Nadaj-Pakleza, A.
    Cassereau, J.
    Baron, C.
    Videt, D.
    Michel, L.
    Pereon, Y.
    Wiertlewski, S.
    Magot, A.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 (11) : 2277 - 2285
  • [36] The effectiveness and safety of vedolizumab induction for moderate to severe ulcerative colitis for Asia patient: A real practice observational study
    Kuo, Chia-Jung
    Le, Puo-Hsien
    Tai, Wei -Chen
    Wu, Keng-Liang
    Yen, Hsu-Heng
    Yen, Chih-Wei
    Tung, Shui-Yi
    Chung, Chen-Shuan
    Su, Ming-Yao
    Chiu, Cheng-Tang
    [J]. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2022, 121 (09) : 1689 - 1695
  • [37] Vedolizumab for ulcerative colitis: Real world outcomes from a multicenter observational cohort of Australia and Oxford
    Pulusu, Samba Siva Reddy
    Srinivasan, Ashish
    Krishnaprasad, Krupa
    Cheng, Daniel
    Begun, Jakob
    Keung, Charlotte
    Van Langenberg, Daniel
    Thin, Lena
    Mogilevski, Tamara
    De Cruz, Peter
    Radford-Smith, Graham
    Flanagan, Emma
    Bell, Sally
    Kashkooli, Soleiman
    Sparrow, Miles
    Ghaly, Simon
    Bampton, Peter
    Sawyer, Elise
    Connor, Susan
    Rizvi, Quart-ul-ain
    Andrews, Jane M.
    Mahy, Gillian
    Chivers, Paola
    Travis, Simon
    Lawrance, Ian Craig
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2020, 26 (30) : 4428 - 4441
  • [38] Vedolizumab for ulcerative colitis:Real world outcomes from a multicenter observational cohort of Australia and Oxford
    Samba Siva Reddy Pulusu
    Ashish Srinivasan
    Krupa Krishnaprasad
    Daniel Cheng
    Jakob Begun
    Charlotte Keung
    Daniel Van Langenberg
    Lena Thin
    Tamara Mogilevski
    Peter De Cruz
    Graham Radford-Smith
    Emma Flanagan
    Sally Bell
    Soleiman Kashkooli
    Miles Sparrow
    Simon Ghaly
    Peter Bampton
    Elise Sawyer
    Susan Connor
    Quart-ul-ain Rizvi
    Jane M Andrews
    Gillian Mahy
    Paola Chivers
    Simon Travis
    Ian Craig Lawrance
    [J]. World Journal of Gastroenterology, 2020, (30) : 4428 - 4441
  • [39] Short and long-term efficacy of adalimumab in ulcerative colitis: a real-life study
    Angelison, Leif
    Almer, Sven
    Davidsdottir, Loa
    Hammarlund, Per
    Lindgren, Stefan
    Hindorf, Ulf
    Marsal, Jan
    Hertervig, Erik
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2020, 55 (02) : 154 - 162
  • [40] Long-term, Real-life, Observational Study in Treating Outpatient Ulcerative Colitis with Golimumab
    Tursi, Antonio
    Mocci, Giammarco
    Elisei, Walter
    Allegretta, Leonardo
    Colucci, Raffaele
    Della Valle, Nicola
    De Medici, Antonio
    Faggiani, Roberto
    Ferronato, Antonio
    Forti, Giacomo
    Larussa, Tiziana
    Lorenzetti, Roberto
    Luzza, Francesco
    Penna, Antonio
    Pranzo, Giuseppe
    Rodino, Stefano
    Sacco, Rodolfo
    Sebkova, Ladislava
    Zampaletta, Costantino
    Graziosi, Camilla
    Picchio, Marcello
    Bergna, Irene Maria Bambina
    Maconi, Giovanni
    [J]. JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2021, 30 (04) : 456 - 461